2Bissell DM, Roulot D, George J. Transforming growth factor beta and the liver. Hepatology, 2001, 34: 859-867.
3Qi Z, Atsuchi N, Ooshima A, et al. Blockade of type beta transforming growth factor signaling prenvents liver fibrosis and dysfunction in the rat. Proc Natl Acad Sci, 1999, 96: 2345-2349.
4Ueno H, Sakamoto T, Nakamura T, et al. A soluble transforming growth factor beta receptor expressed in muscle prevents liver fibrogensis and dysfunction in rats. Hum Gene Ther, 2000, 11: 33-42.
5Choi ME, Kim EG, Huang Q, et al. Rat mesangial cell hypertrophy in response to transforming growth factor-beta 1. Kidney Iht, 1993,44: 948-958.
6Roulot D, Sevcsik AM, Coste T, et al. Role of transforming growth factor beta type Ⅱ receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats. Hepatology,1999, 29: 1730-1738.
7Paizis G, Gilbert RE, Cooper ME, et al. Effect of angiotensin Ⅱ type 1 receptor blockade on experimental hepatic fibrogenesis. J Hepatol,2001, 35: 376-385.
8Wang YQ, Ikeda K, Ikebe T, et al. Inhibition of hepatic stellate cell proliferation and activation by the semisynthetic analogue of fumagillin TNP-470 in rats. Hepatology, 2000, 32: 980-989.
9陈奇,主编.中药药理研究方法学.北京:人民卫生出版社,1993.846-846.
10De Bleser PJ, Niki T, Rogiers V, et al. Transforming growth factorbeta gene expression in normal and fibrotic rat liver. J Hepatol,1997, 26: 886-893.
